8th Global Pharmaceutical Quality Summit 2023
The Indian Pharmaceutical Alliance (IPA) on 23 June successfully concluded the 8th edition of the Global Pharmaceutical Quality Summit at Mumbai.
An overview of the news
The theme for the Summit was, ‘Patient Centricity: New Paradigm of Manufacturing and Quality’.
The two-day Summit brought together industry leaders, global regulators, quality experts, and stakeholders to foster knowledge exchange and deliberate on areas of importance in shaping the pharmaceutical landscape in India.
The event was inaugurated by Samir Mehta, Chairman, Torrent Pharmaceuticals and President, IPA.
Dr. Mansukh Mandaviya, Union Minister for Chemicals and Fertilizers and Health and Family Welfare addressed the summit.
India played a vital role as the "Pharmacy to the World" during the COVID-19 pandemic by ensuring a steady supply of quality medicines and vaccines across the globe.
The Indian pharmaceutical industry has demonstrated its potential both in terms of quality and quantity.
About the Indian Pharmaceutical Alliance (IPA)
IPA was established in the year 1999 in Mumbai.
IPA represents 24 research-based national pharmaceutical companies.
Collectively, the IPA companies contribute to over 85 percent of the private sector investment in pharmaceutical research and development in India.
IPA companies are responsible for more than 80 percent of the country's exports of drugs and pharmaceuticals.
They also serve over 60 percent of the domestic market in India.
Please Rate this article, so that we can improve the quality for you -